Stephens Reiterates Overweight Rating for Privia Health Group (NASDAQ:PRVA)

Stephens reiterated their overweight rating on shares of Privia Health Group (NASDAQ:PRVA) in a report published on Thursday,Benzinga reports. The brokerage currently has a $26.00 price target on the stock.

Other equities analysts also recently issued research reports about the company. KeyCorp began coverage on Privia Health Group in a research report on Friday, October 11th. They set an “overweight” rating and a $23.00 target price on the stock. Truist Financial boosted their target price on shares of Privia Health Group from $24.00 to $27.00 and gave the company a “buy” rating in a research note on Friday, November 8th. Macquarie initiated coverage on shares of Privia Health Group in a report on Monday, December 16th. They set an “outperform” rating and a $25.00 price objective for the company. Barclays upped their target price on shares of Privia Health Group from $19.00 to $21.00 and gave the stock an “equal weight” rating in a research note on Friday, November 8th. Finally, JPMorgan Chase & Co. boosted their price target on Privia Health Group from $27.00 to $28.00 and gave the company an “overweight” rating in a report on Friday, November 29th. Two research analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Buy” and an average price target of $24.88.

Privia Health Group Trading Up 1.6 %

Shares of NASDAQ PRVA opened at $19.96 on Thursday. Privia Health Group has a 12-month low of $15.92 and a 12-month high of $23.78. The firm’s 50-day moving average price is $20.71 and its 200-day moving average price is $19.32. The stock has a market capitalization of $2.40 billion, a price-to-earnings ratio of 199.62, a P/E/G ratio of 5.45 and a beta of 0.83.

Institutional Investors Weigh In On Privia Health Group

Several institutional investors have recently added to or reduced their stakes in the business. Canada Pension Plan Investment Board purchased a new position in shares of Privia Health Group in the 2nd quarter valued at approximately $26,000. GAMMA Investing LLC raised its stake in Privia Health Group by 98.7% in the 3rd quarter. GAMMA Investing LLC now owns 1,701 shares of the company’s stock worth $31,000 after acquiring an additional 845 shares during the last quarter. Signaturefd LLC lifted its position in Privia Health Group by 46.3% during the 2nd quarter. Signaturefd LLC now owns 1,978 shares of the company’s stock worth $34,000 after acquiring an additional 626 shares during the period. Quarry LP increased its holdings in shares of Privia Health Group by 344.6% in the third quarter. Quarry LP now owns 3,268 shares of the company’s stock valued at $60,000 after purchasing an additional 2,533 shares during the period. Finally, KBC Group NV increased its holdings in shares of Privia Health Group by 34.6% in the third quarter. KBC Group NV now owns 3,385 shares of the company’s stock valued at $62,000 after purchasing an additional 871 shares during the period. Institutional investors and hedge funds own 94.48% of the company’s stock.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.